2020•Multiple Sclerosis and Related DisordersOpen access

COVID-19 and multiple sclerosis: A description of two cases on alemtuzumab

Eva María Fernández-Diaz, Julia Gracia Gil, José Gregorio García-García, María Palao, Carlos Sánchez, Tomás Segura

Open full text 26 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

Open-access reader

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 26 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Alemtuzumab, Multiple sclerosis, Medicine, Coronavirus disease 2019 (COVID-19), Immunosuppression, Relapsing remitting, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), 2019-20 coronavirus outbreak

Related papers

Back to paper searchBrowse research topicsOriginal source
COVID-19 and multiple sclerosis: A description of two cases on alemtuzumab — Research Paper | ScholarLens